Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia

Published:2019-06-10 Issue:16 Volume:25 Page:5038-5048
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Tarlock Katherine,Alonzo Todd A.,Wang Yi-Cheng,Gerbing Robert B.,Ries Rhonda,Loken Michael R.,Pardo Laura,Hylkema Tiffany,Joaquin Jason,Sarukkai Leela,Raimondi Susana C.,Hirsch Betsy,Sung Lillian,Aplenc Richard,Bernstein Irwin,Gamis Alan S.,Meshinchi Soheil,Pollard Jessica A.

Funder

St. Baldrick's Foundation

Hyundai Motor Group | Hyundai Motor America | Hyundai Hope On Wheels (Hope On Wheels)

HHS | NIH | National Cancer Institute (NCI)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the interplay between microRNA expression and DNA mutation analysis in AML patients;Saudi Journal of Biological Sciences;2024-07

2. t(2;2;21;8)(p21;q37;q22;q22), a novel four-way complex translocation involving variant t(8;21) in case of acute myeloid leukemia : A case report and literature review;Cancer Genetics;2024-06

3. Prognostic Factors of Pediatric Acute Myeloid Leukemia Patients with t(8;21) (q22;q22): A Single-Center Retrospective Study;Children;2024-05-17

4. KIT‐mutated pediatric core‐binding factor systemic mastocytosis‐acute myeloid leukemia treated with avapritinib and decitabine;Pediatric Blood & Cancer;2024-01-30

5. Chromosomal and Genomic Alterations in Pediatric AML;Pediatric Oncology;2024